The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, ...

Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...

Federal regulators have asked Novavax (NVAX) to conduct another randomized clinical trial of its Covid-19 vaccine following earlier delays in ...

CHICAGO, April 24 (Reuters) - Thousands of Americans campaigning for the Novavax (NVAX.O), opens new tab COVID-19 booster got some good news this week: the FDA signaled it might still win approval ...

Just 13 percent of children have gotten the latest Covid shot, according to the most recent CDC data. And after Republicans, ...